Kiniksa Pharmaceuticals International, plc (KNSA)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q2-2026 | 8-K (2026-07-28) · 99.1 | ||
| 10-Q | Q1-2026 | 8-K (2026-04-28) · 99.1 | ||
| 10-KLatest | FY-2025 | 8-K (2026-02-24) · 99.1 | 8-K (2026-01-12) · 99.1 | ||
| 10-Q | Q3-2025 | 8-K (2025-10-28) · 99.1 | ||
| 10-Q | Q2-2025 | 8-K (2025-07-29) · 99.1 | ||
| 10-Q | Q1-2025 | 8-K (2025-04-29) · 99.1 | ||
| 10-K | FY-2024 | 8-K (2025-02-25) · 99.1 | 8-K (2025-01-13) · 99.1 | ||
| 10-Q | Q3-2024 | 8-K (2024-10-29) · 99.1 | ||
| 10-Q | Q2-2024 | 8-K (2024-07-23) · 99.1 | ||
| 10-Q | Q1-2024 | 8-K (2024-04-23) · 99.1 | ||
| 10-K | FY-2023 | 8-K (2024-02-28) | 8-K (2024-01-04) · 99.1 · 99.2 | ||
| 10-Q | Q3-2023 | 8-K (2023-10-31) · 99.1 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Document and Entity Information | ||
| Statements | ||
| Consolidated Balance Sheets | ||
| Consolidated Balance Sheets (P) | ||
| Condensed Consolidated Statements of Operations and Comprehensive Income | — |
|
| Consolidated Statements of Operations and Comprehensive Income (loss) | ||
| Consolidated Statements of Operations and Comprehensive Loss | — |
|
| Consolidated Statements of Shareholders' Equity | ||
| Consolidated Statements of Cash Flows | ||
| Notes | ||
| Accrued Expenses | ||
| Benefit Plans | — |
|
| Commitments and Contingencies | ||
| Common Shares | — |
|
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Fair Value of Financial Assets and Liabilities | ||
| Income Taxes | ||
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Intangible Assets | ||
| Inventory | ||
| Leases | ||
| License and Acquisition Agreements | ||
| Nature of The Business and Basis of Presentation | ||
| Net Income (loss) Per Share | ||
| Net Income Per Share | — |
|
| Net Loss Per Share | — |
|
| Ordinary Shares | — |
|
| Out-licensing Agreements | ||
| Pay Vs Performance Disclosure | ||
| Product Revenue, Net | ||
| Property and Equipment, Net | ||
| Segment Information | ||
| Segment Information and Geographic Data | ||
| Share-based Compensation | ||
| Subsequent Events | — |
|
| Summary of Significant Accounting Policies | — |
|